Guía de práctica clínica para el diagnóstico y tratamiento de la infección por helicobacter pylori en adultos: actualización 2025

Introducción: en 2015, la Asociación Colombiana de Gastroenterología (ACG) publicó la guía de práctica clínica (GPC) para el diagnóstico y tratamiento de la infección por Helicobacter pylori en adultos. En 2025, la Asociación realizó el proceso de actualización de esta guía de acuerdo con la necesidad de actualización de las estrategias diagnósticas y terapéuticas, adaptadas a la realidad microbiológica local y a las características clínicas de la población. Materiales y métodos: el comité de guías de la ACG con el acompañamiento de epidemiólogos realizó la actualización con base en una revisión sistemática de recomendaciones de práctica y metaanálisis siguiendo las directrices de la metodología GRADE. En esta versión corta de la GPC-actualización 2025 se presenta un breve resumen de la evidencia que apoya las recomendaciones. El detalle del proceso de actualización puede consultarse en la versión completa disponible en www.gastrocol.com. Resultados: la actualización de 2025 presenta recomendaciones sobre indicaciones de tratamiento para curar el H. pylori y prevenir otras patologías, métodos diagnósticos invasivos y no invasivos, alternativas de tratamiento en las diferentes líneas y consideraciones particulares como zonas de alta resistencia, alergia a la penicilina y poblaciones especiales. Conclusión: un adecuado diagnóstico y tratamiento de la infección por H. pylori es esencial dado su rol como factor de riesgo en condiciones como gastritis crónica, úlceras pépticas, linfoma MALT gástrico y adenocarcinoma del estómago.

• Publication year

  2025

• Venue

  Revista Colombiana de Gastroenterología

• Publication date

  2025-11-10

• Fields of study

  Not labeled

• Identifiers
  DOI 10.22516/25007440.1458
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Seven‐Day Versus 14‐Day Tegoprazan and Tetracycline‐Containing Quadruple Therapy for First‐Line Eradication of Helicobacter pylori Infection: A Randomized, Open‐Label, Noninferiority Trial

  2025cited by this paper
• The Association Between Helicobacter pylori Infection and Eosinophilic Esophagitis: Systematic Review and Meta‐Analysis

  2025cited by this paper
• Bloqueadores ácidos competitivos de potasio (PCABs): estado del arte

  2025cited by this paper
• OLGA and OLGIM staging systems on the risk assessment of gastric cancer: a systematic review and meta‑analysis of prospective cohorts

  2025cited by this paper
• Efficacy and safety of tetracycline vs. amoxicillin in furazolidone-based rescue therapy for Helicobacter pylori: a real-world analysis

  2025cited by this paper
• Eradication Therapy to Prevent Gastric Cancer in H. pylori-positive individuals: Systematic Review and Meta-analysis of Randomized Controlled Trials and Observational Studies.

  2025cited by this paper
• Therapeutic regimens against Helicobacter pylori infection without proton pump inhibitors in patients with corpus atrophic gastritis: a real-life single-centre longitudinal observational study

  2025cited by this paper
• Screening and eradication of Helicobacter pylori for gastric cancer prevention: Taipei Global Consensus II

  2025cited by this paper
• The Impact of Probiotics on Helicobacter pylori Eradication with Bismuth Quadruple Therapy: A Systematic Review and Meta-Analysis.

  2025cited by this paper
• Helicobacter pylori eradication and gastric cancer prevention in a pooled analysis of large-scale cohort studies in Japan

  2025cited by this paper
• The Cost-Effectiveness of Adding Helicobacter Pylori Screening to the National Gastric Cancer Screening Program in Korea: Protocol for a Cost-Effectiveness Modeling Study

  2025cited by this paper
• Comparative Efficacy and Safety of Potassium-Competitive Acid Blocker– and Proton Pump Inhibitor–Based Bismuth Quadruple Therapy for Helicobacter pylori Eradication: A Network Meta-Analysis

  2025cited by this paper
• A scoping review of worldwide guidelines for diagnosis and treatment of Helicobacter pylori infection

  2025cited by this paper
• Update on the association between Helicobacter pylori infection and asthma in terms of microbiota and immunity

  2024cited by this paper
• Global prevalence of Helicobacter pylori infection and incidence of gastric cancer between 1980 and 2022.

  2024cited by this paper
• AGA Clinical Practice Update on Screening and Surveillance in Individuals at Increased Risk for Gastric Cancer in the United States: Expert Review.

  2024cited by this paper
• Real‐Time Assessment of H. pylori Infection to Guide Molecular Antibiotic Resistance Testing: A Combined Endoscopy‐Gastric Juice Analysis Approach

  2024cited by this paper
• Comparative Efficacy and Safety of Potassium‐Competitive Acid Blockers and Proton Pump Inhibitors for First‐Line Helicobacter pylori Eradication Therapy: A Systematic Review and Network Meta‐Analysis

  2024cited by this paper
• Peptic Ulcer Disease: A Review.

  2024cited by this paper
• Optimization of Minocycline‐Containing Bismuth Quadruple Therapy for Helicobacter pylori Rescue Treatment: A Real‐World Evidence Study

  2024cited by this paper
• AGA Clinical Practice Update on Integrating Potassium-Competitive Acid Blockers Into Clinical Practice: Expert Review.

  2024cited by this paper
• AGA Clinical Practice Update on Pregnancy-Related Gastrointestinal and Liver Disease: Expert Review.

  2024cited by this paper
• ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.

  2024cited by this paper
• Simplified Helicobacter pylori therapy for patients with penicillin allergy: a randomised controlled trial of vonoprazan-tetracycline dual therapy

  2024cited by this paper
• Urea breath test for Helicobacter pylori infection in adult dyspeptic patients: A meta-analysis of diagnostic test accuracy

  2024cited by this paper
• Actualización en el tratamiento de Helicobacter pylori: revisión del LATAMGCHMSG

  2024cited by this paper
• Effectiveness of Helicobacter pylori Treatments According to Antibiotic Resistance

  2023cited by this paper
• Management of Helicobacter pylori treatment failures: A large population-based study (HP treatment failures trial)

  2023cited by this paper
• Effect of Helicobacter pylori eradication on gastric precancerous lesions: A systematic review and meta‐analysis

  2023cited by this paper
• Effectiveness of Helicobacter pylori eradication in the treatment of early-stage gastric mucosa-associated lymphoid tissue lymphoma: An up-to-date meta-analysis

  2023cited by this paper
• Tratamiento cuádruple con doxiciclina, furazolidona, bismuto e inhibidor de bomba de protones sigue siendo efectivo frente al Helicobacter pylori en nuestra población

  2023cited by this paper
• Efficacy and safety of minocycline quadruple therapy for Helicobacter pylori eradication: A meta‐analysis of RCTs

  2023cited by this paper
• Helicobacter pylori Treatment and Gastric Cancer Risk after Endoscopic Resection of Dysplasia: A Nationwide Cohort Study.

  2023cited by this paper
• Do atrophic gastritis and intestinal metaplasia reverse after Helicobacter pylori eradication?

  2023cited by this paper
• Efficacy of bismuth for antibiotic‐resistant Helicobacter pylori strains eradication: A systematic review and meta‐analysis

  2022cited by this paper
• Treatment regimens used in the management of Helicobacter pylori in Colombia

  2022cited by this paper
• Gastrointestinal microbiome and Helicobacter pylori: Eradicate, leave it as it is, or take a personalized benefit–risk approach?

  2022cited by this paper
• Evolution of Diagnostic Methods for Helicobacter pylori Infections: From Traditional Tests to High Technology, Advanced Sensitivity and Discrimination Tools

  2022cited by this paper
• Experience with Rifabutin-Containing Therapy in 500 Patients from the European Registry on Helicobacter pylori Management (Hp-EuReg)

  2022cited by this paper
• Helicobacter pylori Infection, Its Laboratory Diagnosis, and Antimicrobial Resistance: a Perspective of Clinical Relevance

  2022cited by this paper
• Sequential eradication of Helicobacter pylori as a treatment for immune thrombocytopenia in patients with moderate thrombocytopenia: a multicenter prospective randomized phase 3 study

  2022cited by this paper
• A Survey of Helicobacter pylori Antibiotic-Resistant Genotypes and Strain Lineages by Whole-Genome Sequencing in China

  2022cited by this paper
• 7‐day versus 14‐day tegoprazan‐based triple therapy to treat Helicobacter pylori infection: Real‐world evidence

  2022cited by this paper
• Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report

  2022cited by this paper
• Guía de práctica clínica para la prevención primaria y secundaria y diagnóstico temprano de cáncer gástrico

  2022cited by this paper
• Efectividad y seguridad del uso de probióticos como adyuvantes en la erradicación de Helicobacter pylori. Revisión sistemática y metaanálisis

  2022cited by this paper
• Diagnosis and Treatment for Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma

  2022cited by this paper
• Ten-Day Vonoprazan-Amoxicillin Dual Therapy as a First-Line Treatment of Helicobacter pylori Infection Compared With Bismuth-Containing Quadruple Therapy

  2022cited by this paper
• AGA Clinical Practice Update on The Management of Refractory Helicobacter pylori Infection: Expert Review

  2021cited by this paper
• Influence of Cytochrome P450 2C19 Genotype on Helicobacter pylori Proton Pump Inhibitor-Amoxicillin-Clarithromycin Eradication Therapy: A Meta-Analysis

  2021cited by this paper
• Systematic review with meta‐analysis: association of Helicobacter pylori infection with gastro‐oesophageal reflux and its complications

  2021cited by this paper
• Doxycycline and minocycline in Helicobacter pylori treatment: A systematic review and meta‐analysis

  2021cited by this paper
• Adverse pregnancy outcomes and Helicobacter pylori infection: A meta‐analysis

  2021cited by this paper
• Susceptibility‐guided versus empirical treatment for Helicobacter pylori infection: A systematic review and meta‐analysis

  2021cited by this paper
• Cost-Effectiveness of Empirical Bismuth-Based Quadruple Therapy and Tailored Therapy After Clarithromycin Resistance Tests for Helicobacter pylori Eradication

  2021cited by this paper
• Whole family—based Helicobacter pylori eradication is a superior strategy to single‐infected patient treatment approach: A systematic review and meta‐analysis

  2021cited by this paper
• Impact of body size on first‐line Helicobacter pylori eradication success using vonoprazan and amoxicillin dual therapy

  2021cited by this paper
• The neglect of adult social care during covid-19

  2020cited by this paper
• Comparison of the Diagnostic Performance of qPCR, Sanger Sequencing, and Whole-Genome Sequencing in Determining Clarithromycin and Levofloxacin Resistance in Helicobacter pylori

  2020cited by this paper
• Optimization Strategies Aimed to Increase the Efficacy of Helicobacter pylori Eradication Therapies with Quinolones

  2020cited by this paper
• European Registry on Helicobacter pylori management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients

  2020cited by this paper
• Review: Diagnosis of Helicobacter pylori infection

  2020cited by this paper
• Helicobacter pylori eradication affects platelet count recovery in immune thrombocytopenia

  2020cited by this paper
• Treatment of Helicobacter pylori in Special Patient Populations

  2019cited by this paper
• The risk of Helicobacter pylori infection for adverse pregnancy outcomes: A systematic review and meta‐analysis

  2019cited by this paper
• Helicobacter pylori: resistencia múltiple en pacientes de Bogotá, Colombia

  2019cited by this paper
• Furazolidone treatment for Helicobacter Pylori infection: A systematic review and meta‐analysis

  2018cited by this paper
• Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection.

  2018cited by this paper
• Helicobacter pylori infection reduces the risk of Barrett's esophagus: A meta‐analysis and systematic review

  2018cited by this paper
• Eradication rate of Helicobacter Pylori infection is directly influenced by adherence to therapy in children

  2017cited by this paper
• Doxycycline in Eradication Therapy of Helicobacter pylori - A Systematic Review and Meta-Analysis

  2016cited by this paper
• The role of endoscopy in the bariatric surgery patient.

  2015cited by this paper
• Iron deficiency anemia in Helicobacter pylori infection: meta-analysis of randomized controlled trials.

  2010cited by this paper
• Guidelines for Prevention of NSAID-Related Ulcer Complications

  2009cited by this paper
• Long-term outcome and short-term survival of patients with systemic lupus erythematosus after bacteraemia episodes: 6-yr follow-up.

  2008cited by this paper
• Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis.

  2007cited by this paper

• 40 años de la Revista Colombiana de Gastroenterología: desafíos y oportunidades

  2025cites this paper